Skip to Main Content

Paper Details

Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors.
J Immunother Cancer
67
2022

Datasets

Release 1.2